RecruitingACTRN12611000598987

Prospective database for the management of venous malformations at Sydney Children's Hospital

Children with venous malformations who are seen at Sydney childrens hospital will have annual bloods to assess the risk of coagulopathy.


Sponsor

Sydney Children's Hospital Randwick

Enrollment

500 participants

Start Date

Jun 7, 2011

Study Type

Observational

Conditions

Summary

Prospective data collection of details of venous malformations and blood screen for coagulopathy


Eligibility

Sex: Both males and femalesMax Age: 18 Yearss

Inclusion Criteria1

  • Venous malformation seen at SCH Randwick

Exclusion Criteria1

  • nil

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

patients will have annual bloods for 5 years to assess coagulopathy (Full blood count, Platelets, plasma fibrinogen, D-dimer, Von Willebrand factor ). Blood willl be taken from direct venous access.

patients will have annual bloods for 5 years to assess coagulopathy (Full blood count, Platelets, plasma fibrinogen, D-dimer, Von Willebrand factor ). Blood willl be taken from direct venous access.


Locations(1)

NSW, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000598987


Related Trials